SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

ExThanks for your review. I welcome both

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
alphapuppy Member Profile
 
Followed By 2
Posts 37
Boards Moderated 0
Alias Born 10/11/07
160x600 placeholder
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/15/2017 4:12:02 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/8/2017 5:28:51 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 5:24:08 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 8/7/2017 5:19:53 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 1:14:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/26/2017 3:21:58 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2017 5:17:26 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/29/2017 4:27:47 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/27/2017 5:02:10 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/19/2017 5:20:48 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/13/2017 5:08:50 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 6/1/2017 10:28:04 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/31/2017 7:37:55 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/26/2017 5:23:00 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 5/17/2017 11:54:01 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/15/2017 5:35:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/25/2017 5:12:52 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 4/17/2017 5:26:07 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 4/17/2017 3:36:14 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/7/2017 2:33:33 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/5/2017 5:17:05 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 3/31/2017 5:28:50 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 3/24/2017 4:38:38 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 3/24/2017 4:32:30 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/23/2017 5:02:14 PM
alphapuppy   Saturday, 08/12/17 11:00:19 AM
Re: exwannabe post# 129662
Post # of 130251 
Ex

Thanks for your review. I welcome both pos and neg comments as I look at as a form of peer review.

I will be formulating a response and include all my methods and data. The problem is the spreadsheets are massive and cannot be posted so I will use some links.

The tail of this model would have a higher uncertainty since I used the IMUC ITT (intent to Treat) survival curves as the initial basis of this model.

I have previously posted a review of the tail of the NWBO trial using a different method.

Please review this post. 121596

Still the model shows statistically significant survival improvement for the experimental arm

Alpha


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist